Travere Therapeutics prices $125M equity offering

seekingalpha
08 Nov 2024
  • Travere Therapeutics (NASDAQ:TVTX) priced an underwritten public offering of ~7.81M shares at a price to the public of $16.00 per share.
  • The gross proceeds from the offering are expected to be $125M.
  • The offering is expected to close on November 12, 2024.
  • Underwriters have a 30-day option to purchase up to an additional 1.17M shares.
  • The stock price dropped 2.3% on Friday during pre-market hours of trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10